Vancouver, British Columbia – (Newsfile Corp. – June 4, 2025) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCTF) (“Beyond Medical” or the “Company”) is pleased to announce the closing of the first tranche of its non-brokered private placement (the “Financing”) for aggregate gross proceeds of CAD $1,680,000 (the equivalent of USD $1,200,000 based on an agreed exchange rate of 1.40:1) in the form of issuance of senior secured non-interest bearing convertible notes (the “Notes”).

The Notes carry the following terms:

• Convertible into common shares of the Company at the option of the holder at a conversion price of CAD $0.41 or 70% of the lowest issuance price of any equity securities issued by the Company (including the conversion price of any convertible instruments) subsequent to the date hereof and prior to the maturity date or a qualified financing, in each case in accordance with applicable securities laws and the policies of the Canadian Securities Exchange. In the event the Company lists its common shares on any foreign exchange, the conversion price shall be at the greater of the Company and the Company’s share price on any such exchange.

• If the Note is not completed prior to maturity, the Company will pay a 24% premium on the outstanding principal.

• The Notes are non-interest bearing and is subject to a statutory hold period of four months and one day in accordance with applicable securities laws.

Use of Proceeds

The net proceeds from the Financing will be used for general working capital and to acquire additional digital assets and artificial intelligence technologies to enhance the Company’s suite of blockchain-powered encryption solutions. The Company’s products are designed to improve data security, reduce operational inefficiencies, and address other critical healthcare needs.

Proceeds may also be used for product development, enhancement of intellectual property, legal costs (including patent and trademark registrations), and further enhance the security and integrity of its blockchain-powered verification ecosystem.

Rebranding to Republic Technologies

In connection with the Financing, Beyond Medical Technologies Inc. is pleased to announce its corporate rebranding to Republic Technologies Inc. The Company has made significant progress in its healthcare-focused artificial intelligence work, completing successful engagements with industry and partners. Feedback from these collaborations has informed key refinements, including on-chain attestations for AI model accuracy and performance transparency. Recent product enhancements allow for solutions across a broader range of industries. The Company has now expanded its technology to support sector-agnostic use cases. The rebrand reflects this broader vision and underscores the Company’s commitment to building open, verifiable data infrastructure that can be applied to good. The rebranding will be rolled out in the coming weeks.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Beyond Medical Technologies Inc.

Beyond Medical Technologies Inc. is a healthcare technology company integrating blockchain infrastructure with AI to enhance outcomes and operational efficiency across the medical ecosystem.

On behalf of the Board of Directors
Daniel Liu, Chief Executive Officer
Email: daniel@beyond-md.ca
https://beyond-md.ca

The Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.

FORWARD-LOOKING STATEMENTS

This news release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation (collectively, “forward-looking statements”). The forward-looking statements herein are made as of the date of this press release and the Company does not intend to, and does not assume any obligation to update or revise them to reflect new information, estimates or opinions, future events or results or otherwise, except as required by applicable law. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements in this news release include, but are not limited to, statements with respect to the anticipated use of proceeds of the Financing, the Company scaling encryption technologies, the integration of blockchain capabilities, the rebranding to Republic Technologies Inc., and statements regarding the Company’s technology and how it may derive from future results.

Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will obtain all necessary regulatory approvals for the Financing and the rebranding, that the proceeds of the Financing will be used as currently anticipated, and that the Company’s plans for growth and the development of its technology and platforms will proceed as currently expected. Although the Company believes that these assumptions and expectations are reasonable, actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what benefits the Company will derive therefrom.

Forward-looking statements reflect the Company’s current beliefs and are based on information currently available to the Company and on assumptions the Company believes to be reasonable. Actual results may differ materially from those anticipated in the forward-looking statements due to risks and uncertainties, including, but not limited to, risks related to the Company’s inability to obtain necessary regulatory approvals; uncertainties associated with the Company’s technology development and integration; changes in market conditions; and other risk factors as discussed in the Company’s continuous disclosure filings, which are available under the Company’s profile on www.sedarplus.ca. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any such statements, whether as a result of new information, future events or otherwise, except as required under applicable securities legislation.

Information in this press release. Neither the Company nor any of its representatives shall have any liability whatsoever for any direct, tort, trust or otherwise, to you or any person resulting from the use of the information in this press release by you or any of your representatives or for omissions from the information in this press release.